Impact Biomedical (IBO) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
IMPACT BIOMEDICAL INC.  (NYSE: IBO)
 

Impact Biomedical Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Impact Biomedical Inc. inventory turnover ratio, the Impact Biomedical Inc.'s ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 2.46 in the second quarter 2026, a new company high. Average inventory processing period, for the Impact Biomedical in Jun 30 2026 quarter, has decreased to 148 days, compare to 235 days, in the Mar 31 2026 quarter.

Within Healthcare sector IMPACT BIOMEDICAL INC. achieved the highest inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1673 in the first quarter 2026, to 1679.

IBO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Impact Biomedical Inc. Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IBO Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -87.24 % -87.12 % - - -
Y / Y Cost of Sales Growth -90.91 % - - - -
Inventory Turnover Ratio (TTM) 2.46 - 1.11 0.03 0.05
IBO's Total Ranking # 1679 # 1673 # # #
Average inventory processing period 148 - 328 11102 8088
Seq. Inventory Growth -1.59 % 0 % -87.01 % -0.21 % -0.61 %
Seq. Cost of Sales Growth - - 41100 % -90.91 % -




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market # 1679

Inventory Turnover Ratio Statistics
High Average Low
2.46 1.71 1.11
(Jun 30 2026)   (Dec 31 2025)



IBO Company Profile >> Back to IBO Efficiency Comparisons >> Compare IBO Inventory Turnover Ratio to its Competitors

Financial Statements
Impact Biomedical's Inventories $ 0 Millions Visit IBO's Balance sheet
Impact Biomedical's Cost of Revenues TTM $ 0 Millions Visit IBO's Income Statement
What are IBO's Sales? Visit IBO's Sales by Segment

Other Inventory Turnover Ratios
Impact Biomedical's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
IBO's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for IBO's Competitors
Inventory Turnover Ratio for IBO's Suppliers
Inventory Turnover Ratio for IBO's Customers

You may also want to know
IBO's Sales Growth Rates IBO's Pe Price to earnings ratio IBO's Receivables Turnover Ratio IBO's Stock Quote
IBO's Net Income Growth Rates IBO's Ps Price to Sales ratio IBO's Sales per Employee IBO's Asset Turnover Ratio
IBO's Net Margin IBO's Pb Price to Book ratio IBO's Financial Strength Ratios IBO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Precipio inc   18.05 $ 15.200  Millions$ 1  Millions
Rockwell Medical inc   17.36 $ 57.537  Millions$ 3  Millions
Neuronetics Inc   16.61 $ 78.345  Millions$ 5  Millions
Cryo cell International Inc   15.87 $ 6.869  Millions$ 0  Millions
Rosecliff Acquisition Corp I  14.94 $ 9.597  Millions$ 1  Millions
Catheter Precision Inc   14.83 $ 1.001  Millions$ 0  Millions
Agape Atp Corporation  14.52 $ 0.413  Millions$ 0  Millions
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Alnylam Pharmaceuticals Inc   11.45 $ 970.735  Millions$ 85  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Irhythm Holdings Inc   10.79 $ 235.967  Millions$ 22  Millions
Genedx Holdings Corp   10.27 $ 140.202  Millions$ 14  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Lantheus Holdings Inc   10.09 $ 619.325  Millions$ 61  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Warby Parker Inc   9.27 $ 414.054  Millions$ 45  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Castle Biosciences Inc   8.14 $ 81.252  Millions$ 10  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions
Nutriband Inc   7.92 $ 1.082  Millions$ 0  Millions
Novavax inc   7.61 $ 88.541  Millions$ 12  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Pulse Biosciences Inc   7.45 $ 1.182  Millions$ 0  Millions

Date modified: 2026-10-15T05:23:37+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.